EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Epidermal Growth Factor Receptor (EGFR) membranous and cytoplasmic overexpression on immunohistochemistry: An additional prognostic marker in oral squamous cell carcinoma

Guddi Rani Singh, Shabana Azad, Tulika Singh, Manish Kumar, Kumari Sunny, Divya Sanehi, Debaditya Haldar

Indian Journal of Pathology and Microbiology · 2025

DOI: 10.4103/ijpm.ijpm_272_24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Pathology and Microbiology, 2025. Verfasst von Guddi Rani Singh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India. Hauptthemen laut MEDLINE: ErbB Receptors, Mouth Neoplasms, Biomarkers, Tumor, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Oral carcinoma is one of the most frequently occurring cancers among Indian men. We conducted this study to find out any association between epidermal growth factor receptor (EGFR) overexpression by immunohistochemical methods with histopathological prognostic parameters like pathological tumor (pT) staging, tumor grade, lymph nodal involvement, extranodal extension (ENE), perineural invasion (PNI), lymphovascular invasion (LVI), and worst pattern of invasion (WPOI). Materials and Methods: This prospective cross-sectional study was conducted in Pathology Department of our institute between December 2021 and November 2022, and a total of 113 confirmed cases of oral squamous cell carcinoma (OSCC) were included in our study. Clinicopathological parameters were recorded, and EGFR expression by immunohistochemistry was evaluated in these patients. The association of EGFR overexpression and the different histopathological parameters according to the College of American Pathologists (CAP) protocol was determined.

Results

Out of 113 cases, 52 cases (46%) were positive for EGFR overexpression on immunohistochemistry. Significant association of EGFR overexpression was noted with pT stage, nodal status N0 versus N1–N2, ENE, PNI, LVI, and WPOI, with P value

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErbB ReceptorsMouth NeoplasmsBiomarkers, TumorCarcinoma, Squamous CellHumansMaleImmunohistochemistryMiddle AgedFemalePrognosisCross-Sectional StudiesProspective StudiesAgedAdultCytoplasmNeoplasm Staging

Stichwörter der Autor:innen

Epidermal growth factor receptororal cancersquamous cell carcinomatumor staging

Substanzen

ErbB ReceptorsEGFR protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India.
  • Department of Pathology, Homi Bhabha Cancer Hospital, Varanasi, Uttar Pradesh, India.
  • Department of Community Medicine, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India.
  • Department of Surgical Oncology, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India.

Zitieren

APA

Singh, G. R., Azad, S., Singh, T., Kumar, M., Sunny, K., Sanehi, D., & Haldar, D. (2025). Epidermal Growth Factor Receptor (EGFR) membranous and cytoplasmic overexpression on immunohistochemistry: An additional prognostic marker in oral squamous cell carcinoma. Indian Journal of Pathology and Microbiology. https://doi.org/10.4103/ijpm.ijpm_272_24

Vancouver

Singh GR, Azad S, Singh T, Kumar M, Sunny K, Sanehi D, et al. Epidermal Growth Factor Receptor (EGFR) membranous and cytoplasmic overexpression on immunohistochemistry: An additional prognostic marker in oral squamous cell carcinoma. Indian Journal of Pathology and Microbiology. 2025. doi:10.4103/ijpm.ijpm_272_24

BibTeX
@article{Singh2025,
  author = {Singh, Guddi Rani and Azad, Shabana and Singh, Tulika and Kumar, Manish and Sunny, Kumari and Sanehi, Divya and Haldar, Debaditya},
  title = {Epidermal Growth Factor Receptor (EGFR) membranous and cytoplasmic overexpression on immunohistochemistry: An additional prognostic marker in oral squamous cell carcinoma},
  journal = {Indian Journal of Pathology and Microbiology},
  year = {2025},
  doi = {10.4103/ijpm.ijpm_272_24}
}
Kostenlos starten →